Protocol No
CONSTELLATION-0610-02
Principal Investigator
Laura Michaelis
Phase
I/II
Summary
This project is being done to evaluate the disease response to CPI-0610 alone or CPI-
0610 in combination with ruxolitinib in patients with Myelofibrosis.
Description
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Sub Category
ClinicalTrials.gov